A HaemSTAR-led, UK-wide 'flash-mob' audit of -intravenous immunoglobulin use in immune -thrombocytopenia.

Phillip Nicolson,Rita Perry,Amelia Fisher,Gemma Scott,Laura Magill,Dominique Chan-Lam, Alice Thorpe,Mac Macheta, Luke Carter-Brzezinski,Sam Ackroyd,Alvin Katumba,Charlotte Bradbury,Sheila Jen,Marquita Camillieri,Martin Besser,Tom Bull,Katherine Leighton,Yezenash Ayalew,John Willan,Edmund Watson,Pamela Oshinyemi,Yogesh Upadhye,Keir Pickard,Imogen Swart-Rimmer,Chloe Knott,Sally Chown,Francesca Crolla,Daire Quinn,Lindsay McLeod-Kennedy, Hajer Oun,Christopher McDermott,Mairi Walker,Ryan Mullally,Naoimh Herlihy,Gulnaz Shah,Andrew Doyle,Susan Robinson,Zara Sayar,Rebecca Pryor,Chris Peet,Amir Shenouda,Indrani Venkatadasari,Jorge Cartier,Melek Akay,Dimitris Tsitsikas,Suthesh Sivapalaratnam,Nichola Cooper,Claire Lentaigne,Chris Bailey,Dan Mei Xu,Sine Janum,Arunodaya Mohan,Katja Kimberger,Maipelo Kgologolo,Belen Sevillano, Sophie Hanina,Akila Danga,Chira Mustafa,Charlotte Wilding,Roochi Trikha, Han Wang,Cristina Crossette-Thambiah,Andrew Hastings,Sree Sreedhara,David Wright,Laura Batey,Abigail Atkin,Sarah Davis,Sarah Jaafar,Ayesha Ejaz,Tina Biss,Jennifer Swieton,Mohd Sharin Mohd Noh,Holly Gibson,Tanya Freeman,Upekha Badaguma,Olivia Kreze,Suriya Kirkpatrick,Surenthini Suntharalingam,Miroslab Kmonicek,Michael Joffe,Dan Halperin,Michael Desborough,Alexandros Rampotas,Elissa Dhillon,Paul Greaves,Edward Blacker,Laura Aiken,Jesca Boot,Nithya Prasannan, Jonathan Kerr,Abi Martin,Sarah Wexler, Claire Burney,Michelle Melly,Regina Nolan,Rupert Hipkins,Israa Kaddam,Shereef Elmoamly,Jennifer Darlow,Dianne Plews,Caroline Shrubsole,Eleana Loizou,Louise Garth,Hina Peter,Julia Wolf,Shivali Walia,Vickie MacDonald,Abbas Zaidi,Robert Dunk,Haroon Miah,Atiqa Miah,David Tucker,Thomas Skinner,Seda Cakmak,Ipek Cakmak,Hayder Hussein,Richard Buka, Lydia Wilson,Georgina Talbot,Hafiz Qureshi,Sarah Wharin,Anna Dillon,Benjamin Bailiff,Graham McIlroy,Duncan Murray,Frances Seymour,Jane Graham, Samuel Harrison,Beena Salhan,David Sharpe,Wayne Thomas,Rory McCulloch,Nicola Crosbie, Gillian Lowe,Quentin Hill

BRITISH JOURNAL OF HAEMATOLOGY（2019）

引用 3|浏览10

暂无评分

摘要

Intravenous immunoglobulin (IVIg) is a common therapy for patients with immune thrombocytopenia (ITP). The initial response rate for IVIg is 80%[1][1] and is typically rapid, with some patients responding in 24 hours, although usually in 2–4 days.[2][2] When IVIg is used alone, the response is

查看译文

关键词

Audit,ITP

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要